Optomed PLC (OPTOMED) - Total Liabilities
Based on the latest financial reports, Optomed PLC (OPTOMED) has total liabilities worth €6.95 Million EUR (≈ $8.12 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Optomed PLC (OPTOMED) equity growth momentum to track the company's year-over-year net asset growth rate.
Optomed PLC - Total Liabilities Trend (2015–2024)
This chart illustrates how Optomed PLC's total liabilities have evolved over time, based on quarterly financial data. See OPTOMED free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Optomed PLC Competitors by Total Liabilities
The table below lists competitors of Optomed PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zoomd Technologies Ltd
V:ZOMD
|
Canada | CA$7.09 Million |
|
Pyung Hwa Ind
KO:090080
|
Korea | ₩221.11 Billion |
|
CHINA MAPLE LE.ED.HD0005
F:CML1
|
Germany | €4.59 Billion |
|
Vivoryon Therapeutics NV
AS:VVY
|
Netherlands | €2.79 Million |
|
Harn Engineering Solutions Public Company Limited
BK:HARN
|
Thailand | ฿404.70 Million |
|
Rocketboots Ltd
AU:ROC
|
Australia | AU$2.01 Million |
|
Aurumin Ltd
AU:AUN
|
Australia | AU$2.66 Million |
|
Nano Labs Ltd
NASDAQ:NA
|
USA | $378.61 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Optomed PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see OPTOMED market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Optomed PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Optomed PLC (2015–2024)
The table below shows the annual total liabilities of Optomed PLC from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €8.14 Million ≈ $9.52 Million |
-6.58% |
| 2023-12-31 | €8.72 Million ≈ $10.19 Million |
-20.44% |
| 2022-12-31 | €10.96 Million ≈ $12.81 Million |
-8.27% |
| 2021-12-31 | €11.95 Million ≈ $13.97 Million |
+8.60% |
| 2020-12-31 | €11.00 Million ≈ $12.86 Million |
-35.19% |
| 2019-12-31 | €16.97 Million ≈ $19.84 Million |
+8.84% |
| 2018-12-31 | €15.59 Million ≈ $18.23 Million |
+78.06% |
| 2017-12-31 | €8.76 Million ≈ $10.24 Million |
+34.62% |
| 2016-12-31 | €6.50 Million ≈ $7.61 Million |
+12.68% |
| 2015-12-31 | €5.77 Million ≈ $6.75 Million |
-- |
About Optomed PLC
Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consultin… Read more